Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape
- PMID: 38303118
- PMCID: PMC10962892
- DOI: 10.1681/ASN.0000000000000302
Assessment of Novel Therapeutics to Improve Access to Transplantation for Highly Sensitized Patients in a Shifting Clinical Landscape
Conflict of interest statement
The author has nothing to disclose.
Comment on
-
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney Transplant.J Am Soc Nephrol. 2024 Mar 1;35(3):347-360. doi: 10.1681/ASN.0000000000000287. Epub 2023 Dec 26. J Am Soc Nephrol. 2024. PMID: 38147137 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
